1. Home
  2. ALLK vs SILC Comparison

ALLK vs SILC Comparison

Compare ALLK & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • SILC
  • Stock Information
  • Founded
  • ALLK 2012
  • SILC 1987
  • Country
  • ALLK United States
  • SILC Israel
  • Employees
  • ALLK N/A
  • SILC N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • SILC Computer Manufacturing
  • Sector
  • ALLK Health Care
  • SILC Technology
  • Exchange
  • ALLK Nasdaq
  • SILC Nasdaq
  • Market Cap
  • ALLK 101.0M
  • SILC 83.4M
  • IPO Year
  • ALLK 2018
  • SILC 1994
  • Fundamental
  • Price
  • ALLK $1.10
  • SILC $15.38
  • Analyst Decision
  • ALLK Hold
  • SILC Hold
  • Analyst Count
  • ALLK 5
  • SILC 1
  • Target Price
  • ALLK $1.67
  • SILC N/A
  • AVG Volume (30 Days)
  • ALLK 306.2K
  • SILC 47.3K
  • Earning Date
  • ALLK 11-06-2024
  • SILC 01-30-2025
  • Dividend Yield
  • ALLK N/A
  • SILC N/A
  • EPS Growth
  • ALLK N/A
  • SILC N/A
  • EPS
  • ALLK N/A
  • SILC N/A
  • Revenue
  • ALLK N/A
  • SILC $62,386,000.00
  • Revenue This Year
  • ALLK N/A
  • SILC N/A
  • Revenue Next Year
  • ALLK N/A
  • SILC $4.15
  • P/E Ratio
  • ALLK N/A
  • SILC N/A
  • Revenue Growth
  • ALLK N/A
  • SILC N/A
  • 52 Week Low
  • ALLK $0.54
  • SILC $11.35
  • 52 Week High
  • ALLK $3.36
  • SILC $19.04
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 52.99
  • SILC 60.13
  • Support Level
  • ALLK $1.00
  • SILC $13.52
  • Resistance Level
  • ALLK $1.11
  • SILC $15.23
  • Average True Range (ATR)
  • ALLK 0.08
  • SILC 0.83
  • MACD
  • ALLK 0.00
  • SILC 0.14
  • Stochastic Oscillator
  • ALLK 47.73
  • SILC 96.26

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Share on Social Networks: